Overview

QVA Mechanistic Efficacy Study (Receptor Effects, Etc)

Status:
Completed
Trial end date:
2017-09-26
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess global ventilated lung volume in moderate to severe COPD patients using MRI lung imaging after treatment with QVA149 compared to placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Glycopyrrolate